Access to Bezuclastinib to be Given With Sunitinib
for the Treatment of Gastrointestinal Stromal Tumors

Full Title

Expanded Access To Bezuclastinib to be Coadministered with Sunitinib For Patients with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors (EAP)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. William Tap’s office at 646-888-4163.